Skip to main content
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

VOR Insider Trading (Vor Biopharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $9,999,990.00
Insider Selling (Last 12 Months): $0.00

Vor Biopharma Insider Trading History Chart

Vor Biopharma Share Price & Price History

$19.50
▼ -0.2 (-1.02%)
As of 05/14/2021 01:00 AM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

Vor Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2021Kush ParmarDirectorBuy555,555$18.00$9,999,990.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vor Biopharma (NYSE:VOR)

Institutional Buying and Selling by Quarter

Vor Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2021Laurion Capital Management LP585,667$25.24M0.1%N/A1.577%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc535,259$23.07M1.7%N/A1.442%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp30,141$1.30M0.0%N/A0.081%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.756$33K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp121,954$5.26M0.0%N/A0.328%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC188,215$8.11M0.0%N/A0.507%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.32,279$1.39M0.0%N/A0.087%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG7,093$0.31M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/11/2021Bollard Group LLC55,555$2.39M0.1%N/A0.150%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund8,600$0.37M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.767,816$33.09M0.0%N/A2.068%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.6,650$0.29M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/6/2021Johnson & Johnson Innovation JJDC Inc.1,074,658$46.32M6.0%N/A2.894%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers9,608$0.41M0.0%N/A0.026%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company 6,427$0.28M0.0%N/A0.017%Search for SEC Filing on Google Icon
4/26/2021Zweig DiMenna Associates LLC20,000$0.86M0.1%N/A0.054%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio2,700$0.12M0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vor Biopharma logo
Vor Biopharma, Inc., early-stage cell therapy company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Vor Biopharma

Today's Range

Now: $19.50
$18.11
$21.21

50 Day Range

MA: $30.96
$19.70
$43.10

52 Week Range

Now: $19.50
$18.11
$63.62

Volume

308,409 shs

Average Volume

233,919 shs

Market Capitalization

$724.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Vor Biopharma?

Vor Biopharma's top insider investors include:
  1. Kush Parmar (Director)

Who are the major institutional investors of Vor Biopharma?

Vor Biopharma's top institutional shareholders include:
  1. Johnson & Johnson Innovation JJDC Inc. — 2.89%
  2. BlackRock Inc. — 2.07%
  3. Laurion Capital Management LP — 1.58%
  4. Sectoral Asset Management Inc — 1.44%
  5. Geode Capital Management LLC — 0.51%
  6. Northern Trust Corp — 0.33%

Which institutional investors are buying Vor Biopharma stock?

Within the previous quarter, VOR stock was acquired by institutional investors including:
  1. Johnson & Johnson Innovation JJDC Inc.
  2. BlackRock Inc.
  3. Laurion Capital Management LP
  4. Sectoral Asset Management Inc
  5. Geode Capital Management LLC
  6. Northern Trust Corp
  7. Bollard Group LLC
  8. JPMorgan Chase & Co.
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel